These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23928282)

  • 1. A systematic review of circulating markers in primary chronic venous insufficiency.
    Smith RK; Golledge J
    Phlebology; 2014 Oct; 29(9):570-9. PubMed ID: 23928282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inflammatory cell biomarkers in chronic venous insufficiency.
    Mosmiller LT; Steele KN; Shrader CD; Petrone AB
    Phlebology; 2017 Oct; 32(9):634-640. PubMed ID: 28379059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins.
    Yasim A; Kilinc M; Aral M; Oksuz H; Kabalci M; Eroglu E; Imrek S
    Phlebology; 2008; 23(1):15-20. PubMed ID: 18361265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of reflux.
    Rohrer MJ; Claytor RB; Garnette CS; Powell CC; Barnard MR; Furman MI; Michelson AD
    Cardiovasc Surg; 2002 Oct; 10(5):464-9. PubMed ID: 12379404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum homocysteine is associated with the severity of primary chronic venous disease.
    Smith RK; Quigley F; Tosenovsky P; Velu R; Bradshaw B; Buettner P; Golledge J
    Phlebology; 2016 Jul; 31(6):409-15. PubMed ID: 26091687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study.
    Budzyń M; Iskra M; Turkiewicz W; Krasiński Z; Gryszczyńska B; Kasprzak MP
    PLoS One; 2018; 13(1):e0191902. PubMed ID: 29377939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed networks of inflammatory mediators characterize chronic venous insufficiency.
    Sachdev U; Vodovotz L; Bitner J; Barclay D; Zamora R; Yin J; Simmons RL; Vodovotz Y
    J Vasc Surg Venous Lymphat Disord; 2018 May; 6(3):358-366. PubMed ID: 29439934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction - a pilot study.
    Shoab SS; Scurr JH; Coleridge-Smith PD
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):334-8. PubMed ID: 10550269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency.
    Feldo M; Woźniak M; Wójciak-Kosior M; Sowa I; Kot-Waśik A; Aszyk J; Bogucki J; Zubilewicz T; Bogucka-Kocka A
    Oxid Med Cell Longev; 2018; 2018():2561705. PubMed ID: 30228853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular treatment of chronic cerebro spinal venous insufficiency in patients with multiple sclerosis modifies circulating markers of endothelial dysfunction and coagulation activation: a prospective study.
    Napolitano M; Bruno A; Mastrangelo D; De Vizia M; Bernardo B; Rosa B; De Lucia D
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):716-20. PubMed ID: 24806325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plasma oxidative stress global index in early stages of chronic venous insufficiency.
    Condezo-Hoyos L; Rubio M; Arribas SM; España-Caparrós G; Rodríguez-Rodríguez P; Mujica-Pacheco E; González MC
    J Vasc Surg; 2013 Jan; 57(1):205-13. PubMed ID: 23182154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency.
    Karahan O; Yavuz C; Kankilic N; Demirtas S; Tezcan O; Caliskan A; Mavitas B
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):684-90. PubMed ID: 26650463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of socio-demographic characteristics and clinical findings on the quality of life of patients with chronic venous insufficiency.
    Soydan E; Yılmaz E; Baydur H
    Vascular; 2017 Aug; 25(4):382-389. PubMed ID: 28007012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):93-8. PubMed ID: 16703224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, presentation and occupational risk factors of chronic venous disease in nurses.
    Diken AI; Yalçınkaya A; Aksoy E; Yılmaz S; Özşen K; Sarak T; Çağlı K
    Phlebology; 2016 Mar; 31(2):111-7. PubMed ID: 25577573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased white cell trapping in the dependent legs of patients with chronic venous insufficiency.
    Thomas PR; Nash GB; Dormandy JA
    J Mal Vasc; 1991; 16(1):35-7. PubMed ID: 2010704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Inflammatory Biomarkers Increased in Varicose Vein Blood?
    Lattimer CR; Kalodiki E; Geroulakos G; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2016 Oct; 22(7):656-64. PubMed ID: 27103338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between homocysteine and endothelial dysfunction markers in stroke disease.
    Abdulle AM; Pathan JY; Moussa N; Gariballa S
    Nutr Neurosci; 2010 Feb; 13(1):2-6. PubMed ID: 20132648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculatory dysfunction in chronic venous insufficiency (CVI).
    Jünger M; Steins A; Hahn M; Häfner HM
    Microcirculation; 2000; 7(6 Pt 2):S3-12. PubMed ID: 11151969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of sulodexide in treatment of chronic venous insufficiency. Results of the ACCORD trial].
    Bogachev VI; Golovanova OV; Malysheva IN
    Angiol Sosud Khir; 2017; 23(3):83-88. PubMed ID: 28902818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.